.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

JUBLIA Drug Profile

« Back to Dashboard

Which patents cover Jublia, and what substitute generic drugs are available?

Jublia is a drug marketed by Dow Pharm and is included in one NDA. There are five patents protecting this drug.

This drug has thirty-one patent family members in eighteen countries.

The generic ingredient in JUBLIA is efinaconazole. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the efinaconazole profile page.

Summary for Tradename: JUBLIA

Patents:5
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list16
Patent Applications: see list13
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:JUBLIA at DailyMed

Pharmacology for Tradename: JUBLIA

Ingredient-typeAzoles
Drug ClassAzole Antifungal
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes7,214,506► Subscribe ► Subscribe
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes8,486,978► SubscribeY ► Subscribe
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes8,039,494► Subscribe ► Subscribe
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes9,566,272► Subscribe ► Subscribe
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: JUBLIA

Country Document Number Estimated Expiration
Canada2706114► Subscribe
Japan2010004893► Subscribe
Russian Federation2010131966► Subscribe
Spain2328785► Subscribe
Japan5623913► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc